Thomas Sciascia

Co-Founder at Trevi Therapeutics, Inc.

Thomas Sciascia

Thomas Sciascia

Co-Founder at Trevi Therapeutics, Inc.

Overview
Career Highlights

Trevi Therapeutics, Inc.

RelSci Relationships

219

Birthday

1954

Age

67

Relationships
RelSci Relationships are individuals Thomas Sciascia likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder, President & Chief Executive Officer at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Principal Accounting Officer & Controller at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Partner & Managing Director at TPG Biotech

Relationship likelihood: Strong

General Partner at New Enterprise Associates

Relationship likelihood: Strong

Chief Financial Officer at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Chief Development Officer at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Development Officer at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Senior Director, Clinical Operations at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Former Co-Founder, President, Chief Executive Officer at Collegium Pharmaceutical, Inc.

Relationship likelihood: Average

Chairman, President & Chief Executive Officer at Rhythm Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to Thomas Sciascia
Potential Connections via
Relationship Science
You
Thomas Sciascia
Co-Founder at Trevi Therapeutics, Inc.
Education
Medical Degree
Class of 1979

Columbia University Irving Medical Center (CUIMC) is a clinical, research, and educational enterprise located on a campus in northern Manhattan. They are home to four professional colleges and schools that provide global leadership in scientific research, health and medical education, and patient care, including: Vagelos College of Physicians and Surgeons, College of Dental Medicine, School of Nursing, Mailman School of Public Health.

Bachelor's of Science Degree in Biology
Class of 1975

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Career History
Medical Director
1997 - 2000

Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA.

Chief Medical Officer
2001 - Prior

Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY.

Faculty Member
1983 - 1997

Boston University (most commonly referred to as BU) is a private research university located in Boston, Massachusetts. The university is nonsectarian, but is historically affiliated with the United Methodist Church. The university has more than 4,000 faculty members and 29,000 students,and is one of Boston's largest employers. It offers bachelor's degrees, master's degrees, and doctoral degrees, and medical and dental degrees through 18 schools and colleges on two urban campuses. The main campus is situated along the Charles River in Boston's Fenway-Kenmore and Allston neighborhoods, while the Boston University Medical Campus is in Boston's South End neighborhood. BU also operates 75 study abroad programs in over 33 cities in over 20 countries and has internship opportunities in 10 different countries (including the United States and abroad).

Transactions
Details Hidden

Trevi Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Trevi Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Trevi Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of treatment for neurologically mediated conditions. It focuses on the formulation of nalbuphine ER, which use to treat chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good on March 17, 2011 and is headquartered in New Haven, CT.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thomas Sciascia. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thomas Sciascia's profile does not indicate a business or promotional relationship of any kind between RelSci and Thomas Sciascia.